Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double Digits

Summary

Celldex Therapeutics received its first FDA approval but experienced a significant stock price decline of double digits following the announcement. The article does not provide additional details regarding the approved drug or indication.